
The FDA approved adrabetadex for infantile-onset NPC based on a 55% lower risk of death vs external controls, with a boxed warning for hearing loss.
This afternoon in the office, a follow-up weight check on a 4-week-old girl reveals, to your consternation, that she is now 10 ounces below her birth weight of 6 lbs, 7 oz.






